Curreio

CRO focused on drug discovery based on structural analysis using a cryo-electron microscope

placeBunkyo, Tokyo, Japan calendar_todayFounded 2019 groups7 employees language curreio.com

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon